We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
One Year No Beer (OYNB) is a community support platform that helps people change their relationship with alcohol. It does this by allowing its users to choose a plan from the company's subscription-based models that consist of a 28-day, 90-day, and 365-day challenge to stay away from alcohol. The platform has empowered 70,000+ people in 90 countries through its challenges. Excess alcohol consumption leads to 3 million deaths per year and costs up to £59 billion to the UK economy alone. OYNB aims to resolve this crisis through its platform. For its efforts, the platform has been mentioned in publications such as the BBC, ITV, Metro, and Daily Telegraph. It also has an online presence of 130,000+ Facebook and 50,000+ Instagram followers. The company will use 42% of the investment to hire personnel, 33% for technology and product builds, and 25% as overhead costs.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,757,111
TOTM makes organic, eco-friendly & reusable period care products. The company is planning to shake up the £29 billion Femcare industry, with 30k+ online and subscription customers, and listings in Tesco, Superdrug and Urban Outfitters and global B2B clients. Having supplied to large corporates including several global institutions, TOTM is ready for global disruption. To this end, the company is raising funds to accelerate global growth across all channels. The proceeds will also be used to expand its product range, grow awareness, secure more distribution and also invest in tech. 

Pitch Rated

77%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £811,400
A new form of electric transport in the bike industry with the use of an affordable and simple conversion kit. Swytch have developed a kinetically rechargeable add-on for existing bikes to convert them into eBikes for a range of up to 50 miles. Funding will result in additional units being manufactured and sold at a 70% margin. The products are available online and currently via 20 independent bike dealers, with over 100 more waiting on stock.
days to go: Expired investment: £349,356
Go Zero is an electric taxi service. Since its inception in 2017, the company has completed over 10,000 journeys, saved an estimated 174 tonnes of CO2, and witnessed £530,000 worth of sales. The UK taxi industry is a £9 billion-pound industry and Go Zero, with its fleet of electric taxis powered by 100% renewable energy sources, aims to be a major disruptor. The company has received 100+ 5-star customer reviews and in 2019, it added 1600 new customers to its network. In February 2020, it launched the Go Zero Network, a network of 1,000 electric taxi franchises across the UK to expand electric travel for all. Being a part of the Go Zero Network offers a franchisee the opportunity to purchase a 5-year licence enabling them to operate their own business under the Go Zero brand. It also gives them the potential to earn between £30,000 and £50,000 after costs, based on performance metrics. With the investment, the company aims to recruit a high performing team to deliver market share, focused on sales, digital marketing, social media, franchise recruitment and management.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £124,530
Vegums develop multivitamin gummies for a vegan and plant-based lifestyle. The company argues that some vitamins are difficult to get from a plant-only diet, such as vitamin D, B12, and iodine. Vegums has researched and incorporated non-animal vitamin ingredients into its products to address that issue. The company asserts that its products are 100% plastic-free and biodegradable. It claims that the number of vegans in the UK grew by 40% in 2020, and shows no sign of slowing down in 2021. It aims to become a contender in this segment. Vegums won the World Plant Award 2020 for the 'Best Plant-Based Start-Up', has a social media following of over 15,700 on Instagram, achieved 4.8/5 on TrustPilot, and scaled from selling 1 pack of Vegums to over 9,000 a month to its customers. It will use the investment for New Product Development (NPD), team expansion, and launching into new markets and countries.
days to go: Expired investment: £312,463
Yapa® is a free social app with an emphasis on your mental health. The application gives a solution to the users to have accurate changes in both mental illness and mental wellness. The application has exceeded 10,000 downloads, and it has 400,000 followers. It has elected former England and Liverpool FC goalkeeper Chris Kirkland as the first ambassador to encourage and build Yapa. The funds will be used for marketing, operation and product innovation.
days to go: Expired investment: £41,930
FTNetwork is a social platform with a mission to represent women in a more meaningful way while challenging social norms. The network is underpinned by 6 years of ongoing diverse research across 19 countries worldwide, reflecting a broad spectrum of women’s interests all across the globe. The company has built a partnership with Wunderman Thompson, part of the WPP Group – the world’s largest advertising holding company. FTNetwork's work has been elaborated upon in 4 part BBC documentary, 'Her Story'. The company has an app available on iOS and Android. The company will use the investment for hiring staff, expanding its product offering to include premium services, spending on revenue operations and general administrative expenses.
days to go: Expired investment: £104,740
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph